ISPOR - Treatment Patterns And Costs Of Patients With Gastrointestinal Stromal Tumor (Gist) Receiving First-Line Imatinib

Full Text

Treatment Patterns And Costs Of Patients With Gastrointestinal Stromal Tumor (Gist) Receiving First-Line Imatinib

Abstract

Authors

B. Seal M. Green D. Stafkey-Mailey M. Eaddy

Back to Volume 16, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now